Keio University in Tokyo said Friday it has started the world’s first clinical test using induced pluripotent stem cells, or iPS cells, to treat patients with spinal cord…
Keio University in Tokyo said Friday it has started the world’s first clinical test using induced pluripotent stem cells, or iPS cells, to treat patients with spinal cord…